Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity
- 1 January 1990
- book chapter
- Published by Elsevier
- Vol. 190, 437-448
- https://doi.org/10.1016/0076-6879(90)90050-b
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Vitamin A-Binding ProteinsNutrition Reviews, 2009
- Teratogenicity of the 13‐cis and all‐trans‐isomers of the aromatic retinoid etretin: Correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral doseTeratology, 1990
- Teratogenicity and placental transfer of All-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in miceToxicology and Applied Pharmacology, 1989
- Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in miceReproductive Toxicology, 1988
- Automated Determination of 13-Cis-and All-Trans-Retinoic Acid, Their 4-Oxo-Metabolites and Retinol in Plasma, Amniotic Fluid and Embryo by Reversed-Phase High-Performance Liquid Chromatography with a Precolumn Switching TechniqueJournal of Liquid Chromatography, 1988
- Toxicity of Retinoids in Humans and AnimalsJournal of Toxicology: Toxin Reviews, 1986
- Retinoic Acid EmbryopathyNew England Journal of Medicine, 1985
- Teratogene Wirkung von Etretinat beim MenschenDeutsche Medizinische Wochenschrift (1946), 1984
- Pharmacokinetics of Isotretinoin Following a Single Oral DoseThe Journal of Clinical Pharmacology, 1982
- Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoidsJournal of the American Academy of Dermatology, 1982